期刊
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
卷 73, 期 4, 页码 338-342出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2012.05.011
关键词
Echinocandins; Antifungal susceptibility; Impaired killing; Serum-based susceptibility testing
资金
- MSD
- Pfizer
- Richter Gedeon Pharma PhD scholarship
- Bolyai Research Scholarship of the Hungarian Academy of Sciences
Micafungin activity was determined against 24 wild-type clinical isolates and 5 American Type Culture Collection strains belonging to 8 Candida species in RPMI-1640 with and without 50% serum using broth microdilution and time-kill methodology. MIC values increased from 4- to 128-folds in 50% serum for all Candida species. Micafungin was not fungicidal against C albicans, C. tropicalis, and against 2 of 3 degrees C. metapsilosis at >= 0.25, 1, and 1 mu g/mL, respectively, after 48 h with 50% serum, showing good fungistatic activity. Fungicidal activity at >= 2, 4, and 32 mu g/mL was noticed against C. glabrata, C inconspicua, and C krusei isolates, respectively. Micafungin at 8-32 mu g/mL showed fungistatic activity against C. parapsilosis and C. orthopsilosis. Serum decreased the in vitro activity of micafungin. With serum binding of echinocandins taken into account, safely fungistatic or fungicidal concentrations seem to require elevated doses against some Candida species, including C. parapsilosis, C. orthopsilosis, and C. krusei. (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据